Filing Details
- Accession Number:
- 0000899243-20-000726
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-01-07 17:00:46
- Reporting Period:
- 2020-01-03
- Accepted Time:
- 2020-01-07 17:00:46
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1351288 | Gw Pharmaceuticals Plc | GWPH | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1645330 | J Catherine Mackey | Sovereign House, Vision Park, Histon Cambridge X0 CB24 9BZ | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Ordinary Shares | Disposition | 2020-01-03 | 1,536 | $8.54 | 17,748 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- Represented by American Depositary Shares of the Issuer ("ADS"). Each ADS represents twelve ordinary shares of the Issuer.
- The price reported in Column 4 is a weighted average price per ordinary share ($102.46 per ADS). These share were sold in multiple transactions at prices ranging from $8.53 per ordinary share ($102.39 per ADS) to $8.54 per ordinary share ($102.47 per ADS), inclusive. The Reporting Person understands to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.